Omegaven in Patients With Rheumatoid Arthritis (ORA-Trial)
NCT00412256
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
DRUG:
Omegaven (10% fish-oil emulsion; Fresenius-Kabi)
Sponsor
Humanis Klinikum Niederosterreich